Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 11, 2013

Primary Completion Date

June 15, 2019

Study Completion Date

July 29, 2019

Conditions
Gastric CancerGastroesophageal Junction Cancer
Interventions
DRUG

Cisplatin-5FU-Afatinib

Trial Locations (15)

11522

2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital, Athens

11525

Dept of Medical Oncology, 251 Air Force Hospital, Athens

11527

"2nd Dept of Internal Medicine, General Hospital of Athens Hippokratio", Athens

11528

"Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens Alexandra", Athens

12462

"Division of Oncology, 2nd Dept of Internal Medicine, University Hospital Attikon", Athens

14564

2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens

3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens

15123

3rd Dept of Medical Oncology, Hygeia Hospital, Athens

18547

1st Dept of Medical Oncology, Metropolitan Hospital, Athens

2nd Dept of Medical Oncology, Metropolitan Hospital, Athens

26504

Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Pátrai

45110

Dept of Medical Oncology, Ioannina University Hospital, Ioannina

56429

Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki

57001

Dept of Medical Oncology, Thermi Clinic S.A, Thessaloniki

71110

Dept of Medical Oncology, University Hospital of Heraklion, Heraklion

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Hellenic Cooperative Oncology Group

OTHER